Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds
申请人:Gamber Gabriel G.
公开号:US20110105496A1
公开(公告)日:2011-05-05
This invention relates generally to methods for the treatment of myosin heavy chain (MyHC)-mediated conditions, and in particular, cardiovascular conditions.
本发明涉及治疗肌球蛋白重链(MyHC)介导的疾病的方法,特别是心血管疾病的方法。